Correlation Between Molecular Pharmacology and Rezolute
Can any of the company-specific risk be diversified away by investing in both Molecular Pharmacology and Rezolute at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Pharmacology and Rezolute into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Pharmacology and Rezolute, you can compare the effects of market volatilities on Molecular Pharmacology and Rezolute and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Pharmacology with a short position of Rezolute. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Pharmacology and Rezolute.
Diversification Opportunities for Molecular Pharmacology and Rezolute
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Molecular and Rezolute is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Pharmacology and Rezolute in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rezolute and Molecular Pharmacology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Pharmacology are associated (or correlated) with Rezolute. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rezolute has no effect on the direction of Molecular Pharmacology i.e., Molecular Pharmacology and Rezolute go up and down completely randomly.
Pair Corralation between Molecular Pharmacology and Rezolute
Given the investment horizon of 90 days Molecular Pharmacology is expected to under-perform the Rezolute. In addition to that, Molecular Pharmacology is 4.09 times more volatile than Rezolute. It trades about -0.15 of its total potential returns per unit of risk. Rezolute is currently generating about -0.01 per unit of volatility. If you would invest 498.00 in Rezolute on August 28, 2024 and sell it today you would lose (19.00) from holding Rezolute or give up 3.82% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Pharmacology vs. Rezolute
Performance |
| Timeline |
| Molecular Pharmacology |
| Rezolute |
Molecular Pharmacology and Rezolute Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Pharmacology and Rezolute
The main advantage of trading using opposite Molecular Pharmacology and Rezolute positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Pharmacology position performs unexpectedly, Rezolute can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rezolute will offset losses from the drop in Rezolute's long position.| Molecular Pharmacology vs. Rezolute | Molecular Pharmacology vs. Tempest Therapeutics | Molecular Pharmacology vs. Forte Biosciences | Molecular Pharmacology vs. Dyadic International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |